Shyam Srinivasan
Stock Analyst at Goldman Sachs
(0.23)
# 4,644
Out of 5,099 analysts
80
Total ratings
42.3%
Success rate
-12.9%
Average return
Main Sectors:
Stocks Rated by Shyam Srinivasan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NSE: DIVISLAB Divi's Laboratories Limited | Upgraded: Buy | ₹6,375 → ₹8,035 | ₹10,015 | -19.77% | 6 | May 29, 2026 | |
| NSE: DRREDDY Dr. Reddy's Laboratories Limited | Downgraded: Sell | ₹1,200 → ₹1,075 | ₹1,370 | -21.50% | 6 | Apr 23, 2026 | |
| NSE: APOLLOHOSP Apollo Hospitals Enterprise Limited | Reiterated: Buy | ₹7,850 → ₹8,550 | ₹8,537 | +0.15% | 2 | Dec 7, 2025 | |
| NSE: FORTIS Fortis Healthcare Limited | Downgraded: Hold | ₹700.00 → ₹965.00 | ₹786.95 | +22.63% | 2 | Dec 7, 2025 | |
| NSE: KIMS Krishna Institute of Medical Sciences Limited | Initiated Coverage: Buy | ₹900.00 | ₹739.70 | +21.67% | 1 | Dec 7, 2025 | |
| NSE: MAXHEALTH Max Healthcare Institute Limited | Initiated Coverage: Buy | ₹1,325 | ₹924.65 | +43.30% | 1 | Dec 7, 2025 | |
| NSE: LAURUSLABS Laurus Labs Limited | Reiterated: Sell | ₹675.00 → ₹750.00 | ₹2,318 | n/a | 8 | Oct 14, 2025 | |
| NSE: NEULANDLAB Neuland Laboratories Limited | Reiterated: Buy | ₹15,750 → ₹17,225 | ₹19,800 | n/a | 5 | Oct 14, 2025 | |
| NSE: BIOCON Biocon Limited | Reiterated: Hold | ₹345.00 → ₹335.00 | ₹341.95 | n/a | 6 | Aug 8, 2025 | |
| NSE: SYNGENE Syngene International Limited | Reiterated: Buy | ₹800.00 → ₹775.00 | ₹413.35 | n/a | 5 | Jul 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,300 → ₹1,250 | ₹1,720 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,375 → ₹1,350 | ₹1,396 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,435 → ₹1,525 | ₹3,162 | n/a | 5 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹2,019 | n/a | 4 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹265.00 → ₹250.00 | ₹236.72 | n/a | 3 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹830.00 → ₹890.00 | ₹532.70 | n/a | 2 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹465.00 | ₹407.95 | n/a | 1 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | ₹1,860 → ₹2,015 | ₹1,704 | n/a | 3 | Jul 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,650 → ₹1,680 | ₹1,749 | n/a | 2 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,325 | ₹1,935 | n/a | 1 | Apr 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,475 → ₹1,500 | ₹1,795 | n/a | 4 | Apr 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | ₹1,350 | ₹446.10 | n/a | 1 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | ₹1,675 | ₹575.25 | n/a | 1 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | ₹1,975 | ₹1,589 | n/a | 1 | Jan 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $0.84 | n/a | 1 | Jul 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $14.30 | n/a | 1 | May 2, 2016 |
Divi's Laboratories Limited
May 29, 2026
Upgraded: Buy
Price Target: ₹6,375 → ₹8,035
Current: ₹10,015
Upside: -19.77%
Dr. Reddy's Laboratories Limited
Apr 23, 2026
Downgraded: Sell
Price Target: ₹1,200 → ₹1,075
Current: ₹1,370
Upside: -21.50%
Apollo Hospitals Enterprise Limited
Dec 7, 2025
Reiterated: Buy
Price Target: ₹7,850 → ₹8,550
Current: ₹8,537
Upside: +0.15%
Fortis Healthcare Limited
Dec 7, 2025
Downgraded: Hold
Price Target: ₹700.00 → ₹965.00
Current: ₹786.95
Upside: +22.63%
Krishna Institute of Medical Sciences Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹900.00
Current: ₹739.70
Upside: +21.67%
Max Healthcare Institute Limited
Dec 7, 2025
Initiated Coverage: Buy
Price Target: ₹1,325
Current: ₹924.65
Upside: +43.30%
Laurus Labs Limited
Oct 14, 2025
Reiterated: Sell
Price Target: ₹675.00 → ₹750.00
Current: ₹2,318
Upside: n/a
Neuland Laboratories Limited
Oct 14, 2025
Reiterated: Buy
Price Target: ₹15,750 → ₹17,225
Current: ₹19,800
Upside: n/a
Biocon Limited
Aug 8, 2025
Reiterated: Hold
Price Target: ₹345.00 → ₹335.00
Current: ₹341.95
Upside: n/a
Syngene International Limited
Jul 24, 2025
Reiterated: Buy
Price Target: ₹800.00 → ₹775.00
Current: ₹413.35
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹1,300 → ₹1,250
Current: ₹1,720
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,375 → ₹1,350
Current: ₹1,396
Upside: n/a
Jul 15, 2025
Reiterated: Sell
Price Target: ₹1,435 → ₹1,525
Current: ₹3,162
Upside: n/a
Jul 15, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹2,019
Upside: n/a
Jul 15, 2025
Reiterated: Buy
Price Target: ₹265.00 → ₹250.00
Current: ₹236.72
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹830.00 → ₹890.00
Current: ₹532.70
Upside: n/a
Jul 8, 2025
Reiterated: Hold
Price Target: ₹465.00
Current: ₹407.95
Upside: n/a
Jul 8, 2025
Reiterated: Buy
Price Target: ₹1,860 → ₹2,015
Current: ₹1,704
Upside: n/a
May 2, 2025
Reiterated: Sell
Price Target: ₹1,650 → ₹1,680
Current: ₹1,749
Upside: n/a
Apr 26, 2025
Reiterated: Sell
Price Target: ₹1,325
Current: ₹1,935
Upside: n/a
Apr 18, 2025
Reiterated: Sell
Price Target: ₹1,475 → ₹1,500
Current: ₹1,795
Upside: n/a
Apr 8, 2025
Initiated Coverage: Buy
Price Target: ₹1,350
Current: ₹446.10
Upside: n/a
Feb 6, 2025
Reiterated: Sell
Price Target: ₹1,675
Current: ₹575.25
Upside: n/a
Jan 19, 2025
Reiterated: Hold
Price Target: ₹1,975
Current: ₹1,589
Upside: n/a
Jul 26, 2021
Reiterated: Hold
Price Target: n/a
Current: $0.84
Upside: n/a
May 2, 2016
Initiated Coverage: Hold
Price Target: n/a
Current: $14.30
Upside: n/a